1.0Next Healthcare North Americahttps://event.businessfrance.fr/next-healthcare-north-americabYoRNA - Next Healthcare North Americarich600338<blockquote class="wp-embedded-content" data-secret="nuKEJmhjJS"><a href="https://event.businessfrance.fr/next-healthcare-north-america/byorna/">bYoRNA</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://event.businessfrance.fr/next-healthcare-north-america/byorna/embed/#?secret=nuKEJmhjJS" width="600" height="338" title="« bYoRNA » — Next Healthcare North America" data-secret="nuKEJmhjJS" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://event.businessfrance.fr/next-healthcare-north-america/wp-includes/js/wp-embed.min.js
</script>
https://event.businessfrance.fr/next-healthcare-north-america/wp-content/uploads/sites/1377/2026/03/adazd.png14941494bYoRNA is developing a platform for designing and manufacturing messenger RNA in yeast, rather than through in vitro transcription (IVT), to produce less immunogenic, less expensive, and more effective drugs. The target market is threefold: cancer immunotherapies, vaccines against infectious diseases, and gene therapies for rare diseases.